AFDO RAPS Healthcare Products Collaborative
BIO
Lowndes David

David

Lowndes

President

DL Advisors

David is the President of DL Advisors LLC where he advises on strategy, acquisitions and provides target assessments and due diligence support. He is an Independent Director on the Boards of SK Pharmteco, a global CDMO operating predominantly in the Pharmaceutical API space, and Yposkesi, a Cell and Gene Therapy CDMO. David has over 37 years of global experience in the Pharmaceutical and Biotechnology Industry, most recently holding Senior Vice President roles at Shire Pharmaceuticals with Global responsibility for Supply Chain and for Manufacturing. David has a degree in Pharmacy from the Welsh School of Pharmacy, University of Wales Institute of Science and Technology (now Cardiff University).

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT

Have questions about our events or how to get involved with one of our committees or workgroups?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative